tiprankstipranks

Garry Arthur Neil Insider Profile

4 Followers
Garry Arthur Neil, CSO at Aevi Genomic Medicine, holds 13.22K shares in Avalo Therapeutics (Ticker: AVTX), holds 0.00 shares in Arena Pharma (Ticker: ARNA), holds 2.16M shares in Aevi Genomic Medicine (Ticker: GNMX).
tipranks
Garry Arthur Neil

Garry Arthur Neil
Aevi Genomic Medicine (GNMX)
CSO

Ranked #33,869 out of 97,825 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+11.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$364K
82.76%
17.24%
0.00%
0.00%
A breakdown of Garry Arthur Neil's holdings

Insider Roles

Oncternal Therapeutics
(ONCT)
Director
Avalo Therapeutics
(AVTX)
CEO & COB, Director
Celldex
(CLDX)
Director
Zura Bio
(ZURA)
Director
Roles that Garry Arthur Neil holds in companies

Most Profitable Insider Trade

Stock:
Aevi Genomic Medicine
(GNMX)
Rating:Informative Buy
Date:Dec 01, 2014 - Dec 01, 2015
Return:+61.90%
The most profitable trade made by Garry Arthur Neil

Garry Arthur Neil's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GNMX
Aevi Genomic Medicine
Dec 09, 2019
Informative Buy
266.42K
$502.08K
Oncternal Therapeutics
Jan 03, 2019
Director
Uninformative Buy
12.50K
$301.42K
ARNA
Arena Pharma
Mar 11, 2022
Uninformative Sell
$0.00
Avalo Therapeutics
Jun 13, 2023
CEO & COB, Director
Uninformative Buy
13.68K
$62.80K
Celldex
Director
Zura Bio
Director
List of latest transactions for each holding click on a transaction to see Garry Arthur Neil's performance on stock

Garry Arthur Neil insider profile FAQ

What is the percentage of profitable transactions made by Garry Arthur Neil?
The percentage of profitable transactions made by Garry Arthur Neil is 33%.
    What is the average return per transaction made by Garry Arthur Neil?
    The average return per transaction made by Garry Arthur Neil is 11.00%.
      What stocks does Garry Arthur Neil hold?
      Garry Arthur Neil holds: GNMX, ONCT, ARNA, AVTX, CLDX, ZURA stocks.
        What was Garry Arthur Neil’s latest transaction?
        Garry Arthur Neil latest transaction was an Uninformative Buy of $13.68K.
          What was Garry Arthur Neil's most profitable transaction?
          Garry Arthur Neil’s most profitable transaction was an Informative Buy of GNMX stock on December 1, 2014. The return on the trade was 61.90%.
            What is Garry Arthur Neil's role in Aevi Genomic Medicine?
            Garry Arthur Neil's role in Aevi Genomic Medicine is CSO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.